The Global Multiplex Assays Market is on a trajectory toward a 5.2 Trillion USD valuation by 2032. While North America continues to lead in revenue, the Asia-Pacific region is emerging as a high-growth hub due to expanding healthcare infrastructure. The move toward point-of-care (POC) multiplexing and AI-driven diagnostics will be the primary catalysts for market expansion in the comi... https://www.databridgemarketresearch.com/nucleus/global-multiplex-assays-market